Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoid signalling modulates susceptibility to traumatic stress exposure
Rebecca J. Bluett, Rita Báldi, Andre Haymer, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 80-102
Open Access | Times Cited: 202
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 188
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Neuropharmacological Modulation of N-methyl-D-aspartate, Noradrenaline and Endocannabinoid Receptors in Fear Extinction Learning: Synaptic Transmission and Plasticity
Simone Battaglia, Chiara Di Fazio, Carmelo M. Vicario, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5926-5926
Open Access | Times Cited: 56
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
Gaurav Bedse, Rebecca J. Bluett, Toni A. Patrick, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 102
An endocannabinoid-regulated basolateral amygdala–nucleus accumbens circuit modulates sociability
Oakleigh M. Folkes, Rita Báldi, Veronika Kondev, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 4, pp. 1728-1742
Open Access | Times Cited: 99
Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening
David J. Marcus, Gaurav Bedse, Andrew D. Gaulden, et al.
Neuron (2020) Vol. 105, Iss. 6, pp. 1062-1076.e6
Open Access | Times Cited: 85
Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?
Leah M. Mayo, Christine A. Rabinak, Matthew N. Hill, et al.
Biological Psychiatry (2021) Vol. 91, Iss. 3, pp. 262-272
Open Access | Times Cited: 66
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
Corneliu N. Stanciu, Mary F. Brunette, Nikhil Teja, et al.
Psychiatric Services (2021) Vol. 72, Iss. 4, pp. 429-436
Open Access | Times Cited: 60
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 57
Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence
Samuel W. Centanni, Bridget Morris, Joseph R. Luchsinger, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 3, pp. 526-537
Open Access | Times Cited: 81
The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression
Jairo Vinícius Pinto, Leonardo Simão Medeiros, Gabriel Santana da Rosa, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 101, pp. 78-84
Closed Access | Times Cited: 62
Cannabinoid interventions for PTSD: Where to next?
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
Sharon Fidelman, Tomer Mizrachi Zer‐Aviv, Rachel Lange, et al.
European Neuropsychopharmacology (2018) Vol. 28, Iss. 5, pp. 630-642
Closed Access | Times Cited: 60
Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala
Farhana Yasmin, Roberto Colangeli, Maria Morena, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 117, Iss. 1, pp. 650-655
Open Access | Times Cited: 60
Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 94, pp. 302-320
Closed Access | Times Cited: 59
2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
Gaurav Bedse, Mathew N. Hill, Sachin Patel
Biological Psychiatry (2020) Vol. 88, Iss. 7, pp. 520-530
Open Access | Times Cited: 54
Endocannabinoid-Based Therapies
Daniele Piomelli, Alex Mabou Tagne
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 483-507
Open Access | Times Cited: 51
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
Lauren Kuhns, Emese Kroon, Karis Colyer‐Patel, et al.
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1231-1249
Open Access | Times Cited: 43
The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism
Raj Kamal Srivastava, Beat Lutz, Iñigo Ruı́z de Azúa
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 32
Endocannabinoid signaling in stress, nausea, and vomiting
Marieka V. DeVuono, Thangam Venkatesan, Cecilia J. Hillard
Neurogastroenterology & Motility (2024)
Open Access | Times Cited: 6
Roles of multiple lipid mediators in stress and depression
Tomoyuki Furuyashiki, Satoshi Akiyama, Shiho Kitaoka
International Immunology (2019) Vol. 31, Iss. 9, pp. 579-587
Open Access | Times Cited: 50
Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies
Sabrina F. Lisboa, Carla Vila-Verde, Jéssica Rosa, et al.
Psychopharmacology (2019) Vol. 236, Iss. 1, pp. 201-226
Closed Access | Times Cited: 48
Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD
Kevin M. Crombie, Brianna N. Leitzelar, Angelique G. Brellenthin, et al.
Biological Psychology (2019) Vol. 145, pp. 1-7
Closed Access | Times Cited: 47
Page 1 - Next Page

Scroll to top